IMC
IMMURON LIMITED
$0.0430
▼ -6.52%
Market cap
$14M
Turnover
$46,815
Last price
$0.0430
Day change
-6.52%
Announcements
5
Range, past year
Open 0.076 · Low 0.026 · Now 0.043 · High 0.098
Open IMC in the full dashboard →
Charts, screener, momentum and signals across every ASX-listed code.
IMC momentum and trend analysis
Our analysis
Independent analysis generated by Stock Trade Intelligence
as at 2026-09-28.
Momentum quality
49/100
Wyckoff phase
Accumulation27d
Trend stage
Neutral
1 Day
-6.5%
1 Week
-4.4%
1 Month
+16.2%
1 Year
-43.4%
RSI
47
Avg daily range
9.1%
IMMURON LIMITED scores 49 out of 100 for momentum quality, a reading rated very low confidence. The score weighs trend structure, price consistency, volume backing and how long the move has held, so a high reading means a sustained trend rather than a single large day. Its trend is currently classified as Neutral.
On the Wyckoff cycle it sits in Accumulation, where it has been for 27 trading days. The weekly timeframe reads Uptrend, which does not yet agree with the daily view.
Against the wider market it is currently outperforming and the institutional accumulation signal reads low.
What stands out
- Fresh trend age (17 days)
- Volume 2.7× 60-day avg
Points to watch
- 60d drawdown -29.5%
- High volatility (ATR 9.1%)
- Thin liquidity
- Risk rating: Very High
- Composite downside risk elevated
IMC announcements
Recent price-sensitive releases.
- 2026-09-04 PROIBS US Distribution Agreement Progress Report
- 2026-08-28 FY26 Results Presentation Company Presentation | Preliminary Final Report
- 2026-08-28 Appendix 4E Preliminary Final Report Preliminary Final Report
- 2026-07-16 Immuron FY26 Sales Update
- 2026-05-28 Response to ASX Price Query
More Health Care stocks
Most traded in the same sector.